The design and rationale of the Beijing Vascular Disease Patients Evaluation Study (BEST study)

Huan Liu1, Jinbo Liu1, Hongwei Zhao1

  • 1Department of Vascular Medicine, Peking University Shougang Hospital, Beijing, 100144, PR China.

Insights

This study identifies traditional and novel risk factors for vascular diseases in a Chinese population. It aims to develop an early detection system using non-invasive vascular assessments and biomarkers.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Epidemiology

Background:

  • Arteriosclerosis and arterial stiffness are key in vascular diseases and predict cardiovascular events.
  • Plasma biomarkers like glucose, lipids, homocysteine (Hcy), and N-terminal pro-brain natriuretic peptide (NT-proBNP) are implicated in arteriosclerosis development.

Purpose of the Study:

  • To prospectively observe subclinical vascular disease characteristics in a Chinese population.
  • To identify non-invasive methods and biomarkers predicting clinical vascular events.
  • To establish an early detection and scoring system for vascular diseases.

Main Methods:

  • Prospective observational 3-year follow-up study of 2858 individuals (45-75 years).
  • Data collection via questionnaires on lifestyle and medical history.
  • Assessment of arterial function (e.g., pulse wave velocity, cardio-ankle vascular index) and structure (e.g., carotid intima-media thickness).
  • Measurement of plasma biomarkers including glucose, lipids, Hcy, NT-proBNP, HbA1c, and insulin resistance index.

Main Results:

  • Baseline data from 2858 subjects collected.
  • Analysis of traditional and novel risk factors for vascular disease progression.
  • Identification of key indicators for subclinical vascular disease.

Conclusions:

  • The study provides crucial information on metabolic risk factors for vascular diseases.
  • It lays the groundwork for a novel early detection system for vascular diseases.
  • The findings will support the development of scoring systems based on comprehensive risk factor and vascular assessment.
Abstract

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
162
Study Design in Statistics01:15

Study Design in Statistics

A study design is a set of techniques that allow a researcher to collect and analyze data from different variables defined for a specific research problem. Statistics is commonly for effective study design and more robust experiments,
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
10.1K
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.0K
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
251
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
383
Bioavailability Study Design: Absolute Versus Relative Bioavailability01:27

Bioavailability Study Design: Absolute Versus Relative Bioavailability

Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
369